Skip to main content

Day: September 8, 2023

Freddie Mac Announces Michael J. DeVito to Retire as CEO

MCLEAN, Va., Sept. 08, 2023 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announced today that Michael J. DeVito has informed the Board of Directors of his intention to retire as Chief Executive Officer in the first quarter of 2024. The Board will begin a search for a successor, and a smooth transition is anticipated. “We are very saddened to hear of Michael’s departure, and the Board expresses its profound appreciation for his strong leadership and his many other contributions to Freddie Mac,” said Sara Mathew, Chair of Freddie Mac’s Board of Directors. “Above all, Michael demonstrated a true passion for the company’s mission and drove meaningful progress in making home possible for homebuyers and renters in communities across the nation.” About Freddie MacFreddie Mac’s mission is to make home possible for families across the nation....

Continue reading

SEALSQ to Report H1 2023 Financial Results on Monday, September 11

Schedules Conference Call for Wednesday, September 13, at 9:00am ET (3:00 pm CET) Tortola, British Virgin Islands , Sept. 08, 2023 (GLOBE NEWSWIRE) — SEALSQ to Report H1 2023 Financial Results on Monday, September 11 Schedules Conference Call for Wednesday, September 13, at 9:00am ET (3:00 pm CET) Tortola, British Virgin Islands – September 8, 2023: SEALSQ Corp (Nasdaq: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that it will issue its H1 2023 financial results for the period ending June 30, 2023, before the open of the market on Monday, September 11, 2023. The company will host a conference call to review its results on Wednesday, September 13, at 9:00 am ET (3:00 pm CET). If you wish to join the...

Continue reading

The Metals Company Announces Investor Conference Schedule Through End of 2023

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, intends to participate at the following in-person conferences being held by leading organizations and financial institutions during the third and fourth quarters of 2023. Recent company updatesOn August 14, TMC announced a Registered Direct Offering at a price of $2.00, a premium of 82% to the TMC closing share price on August 11 On August 1, TMC provided a corporate update on expected development timeline, production capacity and application costs for its NORI-D Nodule Project following the recent International Seabed Authority (ISA) Council decisions on a roadmap to deliver final rules, regulations and procedures, also known as the Mining Code In...

Continue reading

Boralex secures Contract for Difference (CfD) for Limekiln Wind Farm in Scotland

WIMBORNE, United Kingdom, Sept. 08, 2023 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce that a Contract for Difference (CfD) has been secured for its Limekiln Wind Farm in Scotland. The UK Department for Energy Security and Net Zero has awarded Boralex’s 108MW wind energy project near Thurso, in the north of Scotland, a 15-year CfD at a level of £52.29/MWh in 2012 prices (equivalent to £72.35/MWh in July 2023 prices). Country Manager Esbjörn Wilmar said: “We are very pleased to have secured a strong CfD for Limekiln. This strike price provides us with the certainty of a stable income and helps to secure project finance. The enabling works have already been completed and the turbine supply agreement with Vestas was signed last year. Having the CfD now in place, with the construction...

Continue reading

Coherus Completes Surface Oncology Acquisition

– Clinical-stage product candidates, casdozokitug and CHS-114, significantly advancenext-generation immuno-oncology portfolio focused on the tumor microenvironment – – I-O combinations will potentially expand toripalimab opportunity into large indications with high unmet need – REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the closing of the previously announced acquisition of Surface Oncology, Inc. (Surface or Surface Oncology), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that target the tumor microenvironment. As a result of the acquisition, Coherus’ novel I-O pipeline now includes four differentiated clinical-stage assets:Toripalimab, a late-stage, anti-PD-1 monoclonal antibody candidate under BLA review...

Continue reading

BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

–Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— –15 Clinical Sites Identified, 12 of the 15 Activated and Recruiting Subjects MELVILLE, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today announced that Northwell Health, New York State’s largest health care provider, has been activated and can now start recruitment in the State of New York for BioRestorative’s ongoing Phase 2 clinical trial targeting chronic lumbar disc disease (“cLDD”). BioRestorative and Northwell Health entered into a clinical trial agreement in May with regard to the Phase 2 trial. Much effort and collaboration have taken place and, now that...

Continue reading

CSX Names Rail Industry Veteran Mike Cory Chief Operating Officer

CSX Appoints Rail Industry Veteran as Chief Operating OfficerMike Cory, a seasoned railroad executive with more than 40 years of operations experience, named executive vice president and chief operating officer at CSX.JACKSONVILLE, Fla., Sept. 08, 2023 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) announced today the appointment of Mike Cory, a seasoned railroad executive with more than 40 years of operations experience, as the company’s executive vice president and chief operating officer. Formerly executive vice president and chief operating officer for the Canadian National (CN) Railway, Cory has provided transportation consulting services since retiring from the CN in 2019. “Mike Cory is one of the rail industry’s leading operations executives, respected for his wealth of operations knowledge and his success as a leader...

Continue reading

Breeze Holdings Acquisition Corp. Announces Preliminary Vote Tabulations for Upcoming Special Meeting and Provides Update on Business Combination Timeline

IRVING, Texas, Sept. 08, 2023 (GLOBE NEWSWIRE) — Breeze Holdings Acquisition Corp. (Nasdaq: BREZ) (the “Company”), today announced that in connection with its upcoming Special Meeting of Stockholders, the Company has already received proxies representing approximately 75.8% of the Company’s total outstanding shares to approve the proposal to extend the date by which the Company must consummate a business combination until as late as June 26, 2024 (the “Proposal”). This is well in excess of the percentage of votes required to approve the Proposal. However, please note that all proxies received by the Company may be revoked at any time before they are exercised at the Special Meeting, which is scheduled to be held on September 22, 2023, at 10:00 a.m. Eastern Time. The purpose of the Proposal is to allow the Company additional time...

Continue reading

Phunware Appoints Mike Snavely as Chief Revenue Officer

AUSTIN, Texas, Sept. 08, 2023 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced today that Mike Snavely has been hired as the Company’s Chief Revenue Officer, effective September 12, 2023. “I am delighted to rejoin Phunware, bringing my experience in SaaS, enterprise software, and channel development at this stage of the Company’s journey,” said Mike Snavely, Chief Revenue Officer of Phunware. “I look forward to working with the phenomenal people at Phunware to help the market reimagine how they engage their customers using our industry-leading, patented Location Services coupled with our hyperlocal mobile engagement platform.” Mike most recently served as the General Manager...

Continue reading

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the publication of its Phase 3 LOCK IT-100 study results in the Clinical Journal of the American Society of Nephrology, or CJASN. The study compared the efficacy and safety of DefenCath®, a catheter lock solution that combines taurolidine 13.5 mg/mL and heparin 1000 USP units/mL, versus heparin alone, in preventing Catheter Related Bloodstream Infections (CRBSIs) in study subjects receiving hemodialysis via central venous catheter (CVC). The randomized, double-blind, active control, Phase 3 study included 795 subjects with kidney failure undergoing hemodialysis...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.